Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure
Status:
Terminated
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of Candesartan, once daily (QD), added
to ongoing chronic heart disease therapy in measuring brain natriuretic peptide in patients
with chronic heart failure.